Corporate Compliance & Transparency in the Pharmaceutical Industry

Learn the full details

Full program in the downloadable agenda.

Download agenda


Day 1

22nd February

Spotlight session: Leveraging ethics and compliance
Workshop: Dealing with Ethics in a principle based company
SPOTLIGHT SESSION: First disclosure year featuring Romania, Poland, Turkey and Spain
The impact of new EU data protection rules
Problem-solving roundtables: Data privacy challenges
Critical aspects of industry – HCPs, ethical interactions & communication
Industry perspective: Framework for cooperation with patient organizations, patient advocacy groups and patients
Patients perspective: Collaboration of patient advocacy groups with pharmaceutical companies
On-stage interview with HCPs/HCOs
Case study: Utilizing data analysis for business purposes and compliance monitoring

Day 2

23rd February

KEYNOTE: EFPIA Disclosure: Second Disclosure Period
Spotlight session: Transparency driven by law
Transparency & disclosure requirements for generics
The Talk: Third-party compliance
Effective monitoring programs & risk assessment
How could the new ISO 37001 Anti-corruption standards shape the compliance world?
The Talk: A compliance culture & KPIs
Multi-stakeholder debate: Compliance role in the future
Fishbowl discussion: Global transparency vs local implementation, featuring examples from Europe, Turkey, Asia and USA